# Allogeneic Hematopoietic Stem Cell Transplantation in Pancreatic Adenocarcinoma

> **NCT02207985** · PHASE1,PHASE2 · TERMINATED · sponsor: **Karolinska Institutet** · enrollment: 10 (estimated)

## Conditions studied

- Pancreatic Adenocarcinoma

## Interventions

- **PROCEDURE:** Allogeneic hematopoietic stem cell transplantation

## Key facts

- **NCT ID:** NCT02207985
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-01
- **Primary completion:** 2017-06-01
- **Final completion:** 2017-06-01
- **Target enrollment:** 10 (ESTIMATED)
- **Why stopped:** Competing studies.
- **Last updated:** 2023-07-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02207985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02207985, "Allogeneic Hematopoietic Stem Cell Transplantation in Pancreatic Adenocarcinoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02207985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*